Recombinant Cetuximab 抗体
MALS verified
适用: 人
宿主: 小鼠
Monoclonal
12B1E9
unconjugated
Recombinant Antibody
-
- 抗原 See all Cetuximab products
- Cetuximab
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Cetuximab antibody is un-conjugated
- 原理
- Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)
- 产品特性
- Anti-idiotypic Antibodies
- 质量等级
- MALS verified
- 免疫原
- Anti-Cetuximab Antibody (12B1E9) (ABIN7482184) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293). The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab ADA.
- 克隆位点
- 12B1E9
-
-
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 储存条件
- -20 °C
-
- 抗原
- Cetuximab
- Abstract
- Cetuximab 产品
- 物质类
- Antibody
- 背景
- Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
-
You are here:
